Femme et Homme
- | Pays :
- United States
- | Organes : -
- | Spécialités : -
Extrait
To document the antitumor activity of capecitabine in combination with erlotinib in patients with previously untreated metastatic colorectal cancer. Time to tumor progression, objective response rate, time to confirmed response rate, duration of confirmed response rate, time to treatment failure, and CEA response will be assessed.
Critère d'inclusion
- Metastatic colorectal cancer